摘要
用ＳＤ１０００型单光子骨矿物仪测定了３１例肾脏疾病患者的骨密度，结果１４例（４５％）骨密度降低，但骨骨各Ｘ线无一例有阳性发现。１２例血透治疗患者中９例有骨密度降低，１９例非透析治疗者仅５例有骨密度降低（Ｐ＜０．０１）。比较骨密度正常或降低者的临床及实验室检查资料，发现骨密度降低者病程较长，肾功能损害更突出，血钙略降低，血磷略升高，血ＰＴＨ和ＡＫＰ无明显变化。本文表明肾性骨病发生率随着肾脏病患者病程延长，病情加重而增加，骨密度测定是发现肾性骨病的一个敏感指标。
In this study the bone mineral density (BMD) in 31 patients with renal diseases was measured by single photon Bone Densitometer (model SD 1 000) The results showed that 14 (45%) of them had decrease of BMD But none of them found abnormal in their bone X ray examination There was BMD decrease in 9 of 12 patients with treatment of hemodialysis But it was only found in 5 of 19 non dialyzed patients Comparing the clinic and laboratory data of patients with normal or decrease of BMD, it was found that the courses of the illness were longer, the impairment of the renal functions was more serious, serum calcium levels were lower and phosphorus levels were higher in patients with BMD decrease, comparison with the data of patients with normal BMD But no significant change was noted on their serum PTH and AKP in these patients It is suggested that the incidence of renal bone disease will increases with the prolongate of the disease’s course and the augmentation of the disease’s seriousness BMD measurement might be a sensitive index for finding renal bone disease
出处
《贵阳医学院学报》
CAS
1997年第1期50-52,共3页
Journal of Guiyang Medical College
关键词
肾疾病
骨密度
肾炎
测定
bone mineral density
renal disease
